Synthetic lethality in cancer therapy: Mechanisms, models and clinical translation for overcoming therapeutic resistance

Documenti analoghi

• RNA methylation‐related inhibitors: Biological basis and therapeutic potential for cancer therapy
  di: Huanxiang Chen, et al.
  Pubblicazione: (2024)
• Lysine‐specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti‐programmed death 1 therapy in liver cancer
  di: Chen Liang, et al.
  Pubblicazione: (2025)
• Engineering exosomes for Alzheimer's disease: Multi‐target therapeutic strategies from pathogenesis to clinical translation
  di: Yuehan Zhang, et al.
  Pubblicazione: (2025)
• STK25 inhibits cancer‐associated fibroblast activation to overcome cetuximab resistance in colorectal cancer
  di: Yifan Hou, et al.
  Pubblicazione: (2026)
• Integrating oncolytic adenoviruses into combination cancer therapy: Mechanisms, advances and clinical outlook
  di: Vlad Iova, et al.
  Pubblicazione: (2026)